LLY
Eli Lilly & Co.
Company · XNYS · US · USD
Market price
$1,183.50
+$55.81 (+4.95%) · 3 months
| Date and time | Price |
|---|---|
| Jun 25, 2026 | $1,127.69 |
| Jun 26, 2026 | $1,208.12 |
| Jun 29, 2026 | $1,229.93 |
| Jun 30, 2026 | $1,199.43 |
| Jul 1, 2026 | $1,191.74 |
| Jul 2, 2026 | $1,213.91 |
| Jul 6, 2026 | $1,200.06 |
| Jul 7, 2026 | $1,235.56 |
| Jul 8, 2026 | $1,215.83 |
| Jul 9, 2026 | $1,216.95 |
| Jul 10, 2026 | $1,188.58 |
| Jul 13, 2026 | $1,181.87 |
| Jul 14, 2026 | $1,152.54 |
| Jul 15, 2026 | $1,156.63 |
| Jul 16, 2026 | $1,169.17 |
| Jul 17, 2026 | $1,179.11 |
| Jul 20, 2026 | $1,146.90 |
| Jul 21, 2026 | $1,175.41 |
| Jul 22, 2026 | $1,163.01 |
| Jul 23, 2026 | $1,185.87 |
| Jul 24, 2026 | $1,196.03 |
| Jul 27, 2026 | $1,197.53 |
| Jul 28, 2026 | $1,220.66 |
| Jul 29, 2026 | $1,210.02 |
| Jul 30, 2026 | $1,154.97 |
| Jul 31, 2026 | $1,148.84 |
| Aug 3, 2026 | $1,121.36 |
| Aug 4, 2026 | $1,115.68 |
| Aug 5, 2026 | $1,169.86 |
| Aug 6, 2026 | $1,191.94 |
| Aug 7, 2026 | $1,185.71 |
| Aug 10, 2026 | $1,231.94 |
| Aug 11, 2026 | $1,215.02 |
| Aug 12, 2026 | $1,220.28 |
| Aug 13, 2026 | $1,209.00 |
| Aug 14, 2026 | $1,180.16 |
| Aug 17, 2026 | $1,183.16 |
| Aug 18, 2026 | $1,225.73 |
| Aug 19, 2026 | $1,280.34 |
| Aug 20, 2026 | $1,244.40 |
| Aug 21, 2026 | $1,255.40 |
| Aug 24, 2026 | $1,246.93 |
| Aug 25, 2026 | $1,233.66 |
| Aug 26, 2026 | $1,189.41 |
| Aug 27, 2026 | $1,176.10 |
| Aug 28, 2026 | $1,174.61 |
| Aug 31, 2026 | $1,156.73 |
| Sep 1, 2026 | $1,160.00 |
| Sep 2, 2026 | $1,160.08 |
| Sep 3, 2026 | $1,159.60 |
| Sep 4, 2026 | $1,149.36 |
| Sep 8, 2026 | $1,123.91 |
| Sep 9, 2026 | $1,124.21 |
| Sep 10, 2026 | $1,123.00 |
| Sep 11, 2026 | $1,115.70 |
| Sep 14, 2026 | $1,138.28 |
| Sep 15, 2026 | $1,136.11 |
| Sep 16, 2026 | $1,137.82 |
| Sep 17, 2026 | $1,152.44 |
| Sep 18, 2026 | $1,152.93 |
| Sep 21, 2026 | $1,164.89 |
| Sep 22, 2026 | $1,170.14 |
| Sep 23, 2026 | $1,150.99 |
| Sep 24, 2026 | $1,183.50 |
- Period change
- +4.95%
- Period low
- $1,115.68
- Period high
- $1,280.34
- Observations
- 64
- Updated
- Sep 24, 2026, 8:00 PM
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Company websiteClassifications
- Biotechnology · Biotech
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNYS
- Operating market
- XNYS
- Country
- US
- Currency
- USD
- Market capitalization
- $1,038,332,931,447.85
- Employees
- 50K